Suki Song's Form 3 Filing as CFO of Anbio Biotechnology

This is a Form 3 filing by Suki Song, who is reporting her initial statement of beneficial ownership of securities in Anbio Biotechnology (ticker: NNNN). The filing indicates that Song holds the position of Chief Financial Officer (CFO) at the company. The filing was signed on April 8, 2026, with a reporting period ending March 18, 2026. Notably, the document states "noSecuritiesOwned: '1'" which indicates that Song currently holds no securities in the company. Song is based in Frankfurt am Main, Germany, and the filing confirms her officer status as CFO. Form 3 filings are required when individuals become officers, directors, or beneficial owners of more than 10% of a company's registered equity securities, even if they currently hold no securities.